KRAS Mutations in Solid Tumors

preview_player
Показать описание
An overview of the normal function of KRAS in cell biology and types of KRAS mutations that present in solid tumor development, including the KRAS G12C mutation in non–small cell lung cancer.

  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
KRAS Mutations in 0:06:52

KRAS Mutations in Solid Tumors

LY3537982: a novel 0:01:19

LY3537982: a novel KRAS G12C inhibitor in solid tumors

ASP3082 in Patients 0:03:38

ASP3082 in Patients With Solid Tumors and KRAS G12D Mutations

AMG 510 for 0:04:06

AMG 510 for targeting KRAS G12C mutant solid tumours

KRAS Mutation Subtypes 0:05:57

KRAS Mutation Subtypes in Advanced NSCLC

KRYSTAL-1: adagrasib for 0:02:54

KRYSTAL-1: adagrasib for KRAS-mutant NSCLC

Novel non-KRAS G12C 0:01:54

Novel non-KRAS G12C inhibitors in solid tumors

AMG 510: A 0:03:26

AMG 510: A novel molecule targeting KRAS G12C mutatant solid tumours

Personalized treatment approaches 0:00:51

Personalized treatment approaches for patients with KRAS-mutant pancreatic cancer

ASCO 2021 Lung 0:05:26

ASCO 2021 Lung Recap: CodeBreak 100: Sotorasib in KRAS G12C Mutation

What is a 0:01:11

What is a KRAS mutation?

We're Finally Beginning 0:04:46

We're Finally Beginning to Crack the KRAS Nut in Colorectal Cancer

Treatment strategies for 0:01:37

Treatment strategies for KRAS-mutant NSCLC with co-mutations

KRAS - Dr 0:10:40

KRAS - Dr Prashanth Bagali - Interpretation Of KRAS Mutation

Dr. Desai on 0:01:53

Dr. Desai on BGB-283 in Patients With BRAF or KRAS/NRAS Solid Tumors

Strategies for Overcoming 0:21:36

Strategies for Overcoming KRAS Mutations

Targeted Therapy for 0:07:23

Targeted Therapy for KRAS-Mutant NSCLC

KRAS-Mutant NSCLC 0:07:00

KRAS-Mutant NSCLC

Treating KRAS G12C 0:01:42

Treating KRAS G12C Mutations

Real-world outcomes by 0:05:14

Real-world outcomes by co-mutation status in KRAS G12C-mutant NSCLC

KRAS Variants, G12C, 0:23:19

KRAS Variants, G12C, TMB, high PD-L1 Expression in Solid Tumors

Voice of Pancreatic 0:45:20

Voice of Pancreatic Cancer Podcast - Targeting the KRAS mutation for more effective cancer treatment

Dr. Cercek on 0:00:57

Dr. Cercek on the Need for Treatment Options in KRAS Mutated mCRC

KRAS-Mutant NSCLC: Current 0:04:42

KRAS-Mutant NSCLC: Current Systemic Treatment Options